美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA202229"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0904-7213-04 0904-7213 HUMAN PRESCRIPTION DRUG Acamprosate Calcium Acamprosate Calcium TABLET, DELAYED RELEASE ORAL 20130716 N/A ANDA ANDA202229 Major Pharmaceuticals ACAMPROSATE CALCIUM 333 mg/1 30 BLISTER PACK in 1 CARTON (0904-7213-04) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK
60687-121-25 60687-121 HUMAN PRESCRIPTION DRUG Acamprosate Calcium Acamprosate Calcium TABLET, DELAYED RELEASE ORAL 20151027 N/A ANDA ANDA202229 American Health Packaging ACAMPROSATE CALCIUM 333 mg/1 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-121-25) / 1 TABLET, DELAYED RELEASE in 1 BLISTER PACK (60687-121-95)
68462-435-11 68462-435 HUMAN PRESCRIPTION DRUG Acamprosate Calcium Acamprosate Calcium TABLET, DELAYED RELEASE ORAL 20130716 N/A ANDA ANDA202229 Glenmark Pharmaceuticals Inc., USA ACAMPROSATE CALCIUM 333 mg/1 10 BLISTER PACK in 1 CARTON (68462-435-11) / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK
68462-435-18 68462-435 HUMAN PRESCRIPTION DRUG Acamprosate Calcium Acamprosate Calcium TABLET, DELAYED RELEASE ORAL 20130716 N/A ANDA ANDA202229 Glenmark Pharmaceuticals Inc., USA ACAMPROSATE CALCIUM 333 mg/1 180 TABLET, DELAYED RELEASE in 1 BOTTLE (68462-435-18)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase